Márcia Lima Bandeira

Learn More
OBJECTIVE This report aims to determine the safety, pharmacokinetics (PK) and efficacy of subcutaneous golimumab in active polyarticular-course juvenile idiopathic arthritis (polyJIA). METHODS In(More)